Jonathan Wygant sold $450K of Veracyte (VCYT)

Executed Nov 7 2025, disclosed Nov 12 2025, 5 days later.

Value, as filed

$450K

10,920 sh across 2 lots

Executed

Nov 7 2025

the trade date, as filed

Disclosed

Nov 12 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jonathan Wygant VP, Chief Accounting Officer profile →

Jonathan Wygant (VP, Chief Accounting Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $1.1M of VCYT (24,000 sh × $45.40, as filed), executed May 22.

The name

VCYT

Veracyte, Inc. VCYT · Healthcare · 50 filings in 24 months ticker →

Healthcare · Veracyte, Inc. operates as a diagnostics company in the United States and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jonathan Wygant in VCYT

VCYTSALE Veracyte, Inc. $1.1M
24,000 sh × $45.40
Exec May 22
Filed May 27 · 5:30 PM ET VCYTSALE Veracyte, Inc. $216K
5,032 sh × $42.89
Exec Nov 27 2024
Filed Nov 29 2024 · 5:30 PM ET